AN 543 (Terbinafine 250 mg)
Pill with imprint AN 543 is White, Round and has been identified as Terbinafine hydrochloride 250 mg. It is supplied by Amneal Pharmaceuticals.
Terbinafine is used in the treatment of onychomycosis, toenail; cutaneous candidiasis; tinea capitis; onychomycosis, fingernail; tinea corporis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Terbinafine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AN 543
Terbinafine hydrochloride
- Imprint:
- AN 543
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Amneal Pharmaceuticals
- Inactive Ingredients:
- silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0805 | AvKare, Inc. |
More about terbinafine
- Terbinafine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 274 Reviews
- Drug class: miscellaneous antifungals
Consumer resources
- Terbinafine
- Terbinafine Tablets and Hydroxypropyl-Chitosan Nail Lacquer
- Terbinafine Tablets
- Terbinafine Oral Granules
- Terbinafine (Advanced Reading)
Other brands: Lamisil, Terbinex
Professional resources
- Terbinafine Hydrochloride (AHFS Monograph)
- Terbinafine (FDA)
- Terbinafine (Systemic) (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
